These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9377103

  • 21. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Garsky VM, Gilbert KF, Leighton JL, Carson KL, Mellin EC.
    J Med Chem; 1993 Dec 24; 36(26):4276-92. PubMed ID: 8277510
    [Abstract] [Full Text] [Related]

  • 22. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
    Harper EA, Griffin EP, Shankley NP, Black JW.
    Br J Pharmacol; 1999 Mar 24; 126(6):1496-503. PubMed ID: 10217545
    [Abstract] [Full Text] [Related]

  • 23. CCK receptor antagonists.
    Dunlop J.
    Gen Pharmacol; 1998 Oct 24; 31(4):519-24. PubMed ID: 9792209
    [Abstract] [Full Text] [Related]

  • 24. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
    Tabuchi S, Ito H, Sogabe H, Kuno M, Kinoshita T, Katumi I, Yamamoto N, Mitsui H, Satoh Y.
    Chem Pharm Bull (Tokyo); 2000 Jan 24; 48(1):1-15. PubMed ID: 10705468
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with modified benzodiazepine skeletons.
    Kawanishi Y, Ishihara S, Tsushima T, Seno K, Hagishita S, Ishikawa M, Ishihara Y.
    Bioorg Med Chem; 1997 Jul 24; 5(7):1411-23. PubMed ID: 9377101
    [Abstract] [Full Text] [Related]

  • 26. Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
    Makovec F, Peris W, Frigerio S, Giovanetti R, Letari O, Mennuni L, Revel L.
    J Med Chem; 1996 Jan 05; 39(1):135-42. PubMed ID: 8568800
    [Abstract] [Full Text] [Related]

  • 27. Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum.
    Patel M, Spraggs CF.
    Br J Pharmacol; 1992 Jun 05; 106(2):275-82. PubMed ID: 1393262
    [Abstract] [Full Text] [Related]

  • 28. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
    Henke BR, Aquino CJ, Birkemo LS, Croom DK, Dougherty RW, Ervin GN, Grizzle MK, Hirst GC, James MK, Johnson MF, Queen KL, Sherrill RG, Sugg EE, Suh EM, Szewczyk JW, Unwalla RJ, Yingling J, Willson TM.
    J Med Chem; 1997 Aug 15; 40(17):2706-25. PubMed ID: 9276016
    [Abstract] [Full Text] [Related]

  • 29. A second generation of non-peptide cholecystokinin receptor antagonists and their possible therapeutic potential.
    Freedman SB, Patel S, Smith AJ, Chapman K, Fletcher A, Kemp JA, Marshall GR, Hargreaves RJ, Scholey K, Mellin EC.
    Ann N Y Acad Sci; 1994 Mar 23; 713():312-8. PubMed ID: 8185173
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with decreased hydrophobicity.
    Kawanishi Y, Ishihara S, Tsushima T, Hagishita S, Ishikawa M, Ishihara Y.
    Bioorg Med Chem; 1997 Jul 23; 5(7):1401-9. PubMed ID: 9377100
    [Abstract] [Full Text] [Related]

  • 31. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A, Anzini M, Vomero S, Menziani MC, De Benedetti PG, Sbacchi M, Clarke GD, Mennuni L.
    J Med Chem; 1996 Feb 16; 39(4):860-72. PubMed ID: 8632410
    [Abstract] [Full Text] [Related]

  • 32. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul 16; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 33. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM.
    J Med Chem; 1989 Jan 16; 32(1):13-6. PubMed ID: 2909725
    [No Abstract] [Full Text] [Related]

  • 34. Quantitative structure-activity relationship studies on cholecystokinin antagonists.
    Gupta SP.
    Curr Pharm Des; 2002 Jan 16; 8(2):111-24. PubMed ID: 11812253
    [Abstract] [Full Text] [Related]

  • 35. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. III.
    Takeda Y, Kawagoe K, Yokomizo A, Yokomizo Y, Hosokami T, Shimoto Y, Tabuchi Y, Ogihara Y, Honda Y, Kawarabayashi K, Iseri M, Yokohama S.
    Chem Pharm Bull (Tokyo); 1999 Jun 16; 47(6):755-71. PubMed ID: 10399834
    [Abstract] [Full Text] [Related]

  • 36. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Veber DF, Freidinger RM, Chang RS, Lotti VJ.
    J Med Chem; 1988 Jan 16; 31(1):176-81. PubMed ID: 3336017
    [Abstract] [Full Text] [Related]

  • 37. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P, Delarge J, Pirotte B.
    Curr Med Chem; 1999 Jun 16; 6(6):433-55. PubMed ID: 10213792
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
    Bellier B, McCort-Tranchepain I, Ducos B, Danascimento S, Meudal H, Noble F, Garbay C, Roques BP.
    J Med Chem; 1997 Nov 21; 40(24):3947-56. PubMed ID: 9397175
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and evaluation of 1,5-benzodiazepines with bridged cycloalkyl substituents at the N-1 position as potent and selective CCK-B Ligands.
    Finizia G, Donati D, Pentassuglia G, Polinelli S, Tarzia G, Tranquillini ME, Ursini A.
    Arch Pharm (Weinheim); 1998 Jan 21; 331(1):41-4. PubMed ID: 9507701
    [Abstract] [Full Text] [Related]

  • 40. Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives.
    Makovec F, Peris W, Revel L, Giovanetti R, Mennuni L, Rovati LC.
    J Med Chem; 1992 Jan 21; 35(1):28-38. PubMed ID: 1732532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.